Details

Evaluation of endocrine disruptome and virtualToxLab for predicting per- and polyfluoroalkyl substances binding to nuclear receptors
ID Franko, Nina (Author), ID Vetrih, Manca (Author), ID Sollner Dolenc, Marija (Author)

.pdfPDF - Presentation file, Download (420,08 KB)
MD5: 63C68FE198D2B7594114551C90481AFE
URLURL - Source URL, Visit https://www.mdpi.com/2039-4713/15/5/136 This link opens in a new window

Abstract
This study investigated whether the Endocrine Disruptome and VirtualToxLab in silico platforms are suitable for predicting the endocrine disrupting effects of per- and polyfluoroalkyl substances (PFASs)—in particular, for interactions with oestrogen receptors (ERs) and androgen receptor (AR). Compounds included in the U.S. Environmental Protection Agency’s PFAS working list were analysed with both models, and the results were compared with the available in vitro data regarding their modulation of nuclear receptors. Based on the identified prediction parameters, such as sensitivity, specificity, accuracy, and Mathews’ correlation coefficient, VirtualToxLab was found to be a reliable model for predicting the reactivity of PFASs with AR, while a positive consensus approach of both platforms provided reliable predictions of the PFAS reactivity with ERα and ERβ. This study provides the evidence that Endocrine Disruptome and VirtualToxLab can be used as a tier 1 screening tool for assessment of the endocrine disrupting effect of PFASs. Furthermore, it demonstrates that the likelihood of endocrine disrupting properties increases with the lipophilicity of PFASs and identifies the understudied PFHpS, PFNS, PFDS, 9-Cl, NMeFOSAA, NEtFOSAA, 4:2 FTS, 6:2 FTS, 8:2 FTS, 6:2 monoPAP, 8:2 monoPAP, and 5:3 acid as potential ligands of AR and/or ERs.

Language:English
Keywords:PFAS, endocrine disruptome, VirtualToxLab, endocrine disruption, androgen receptor, estrogen receptor, glucocorticoid receptor, in silico, new approach methods, hormonski motilci, imunomodulacija
Work type:Article
Typology:1.01 - Original Scientific Article
Organization:FFA - Faculty of Pharmacy
Publication status:Published
Publication version:Version of Record
Year:2025
Number of pages:21 str.
Numbering:Vol. 15, iss. 5, [article no.] 136
PID:20.500.12556/RUL-171388 This link opens in a new window
UDC:616.4
ISSN on article:2039-4713
DOI:10.3390/jox15050136 This link opens in a new window
COBISS.SI-ID:246382595 This link opens in a new window
Publication date in RUL:25.08.2025
Views:177
Downloads:55
Metadata:XML DC-XML DC-RDF
:
Copy citation
Share:Bookmark and Share

Record is a part of a journal

Title:Journal of xenobiotics
Shortened title:J. xenobiotics
Publisher:PagePress Publications
ISSN:2039-4713
COBISS.SI-ID:520181017 This link opens in a new window

Licences

License:CC BY 4.0, Creative Commons Attribution 4.0 International
Link:http://creativecommons.org/licenses/by/4.0/
Description:This is the standard Creative Commons license that gives others maximum freedom to do what they want with the work as long as they credit the author.

Secondary language

Language:Slovenian
Keywords:PFAS, endokrine motnje, VirtualToxLab, endokrine motnje, androgeni receptor, estrogenski receptor, glukokortikoidni receptor, in silico, nove metode pristopa

Projects

Funder:ARIS - Slovenian Research and Innovation Agency
Project number:P1-0208
Name:Farmacevtska kemija: načrtovanje, sinteza in vrednotenje učinkovin

Similar documents

Similar works from RUL:
Similar works from other Slovenian collections:

Back